Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction

Chinese Medical Journal

Volumn 121, Issue 23, 2008, Pages 2374-2378

  Liu, Yu ^a   Wang, Le Feng ^a   Yang, Xin Chun ^a   Ge, Yong Gui ^a   Wang, Hong Shi ^a   Xu, Li ^a   Li, Wei Ming ^a   Ni, Zhu Hua ^a   Xia, Kun ^a   Chi, Yong Hui ^a   Li, Qiang ^a   Zhang, Da Peng ^a   Wu, Xiao Qing ^a   Sun, Hao ^a   Guo, Zong Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gender; Myocardial infarction; Outcomes; Percutaneous coronary intervention

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD CLOT LYSIS; BYPASS SURGERY; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; EMERGENCY SURGERY; FEMALE; FOLLOW UP; GENDER BIAS; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION; STENOSIS; TREATMENT RESPONSE; CLINICAL TRIAL; METHODOLOGY; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEX FACTORS; TREATMENT OUTCOME;

EID: 63149129327     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200812010-00002     Document Type: Article

References (24)

1. MacIntyre K, Stewart S, Capewell S, Chalmers JW, Pell JP, Boyd J, et al. Gender and survival: a population-based study of 201 114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001; 38: 729-735.
2. Hanratty B, Lawlor DA, Robinson MB, Sapsford RJ, Greenwood D, Hall A, et al. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. J Epidemiol Community Health 2000; 54: 912-916.
3. Brodie BR, Stuckey TD, Wall TC, Kissling G, Hansen CJ, Muncy DB, et al. Improtance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998; 32: 1312-1319.
4. Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Ni J, et al. One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease. Chin Med J 2006; 119: 165-168.
5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
6. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L, et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000; 343: 8-15.
7. Mahon NG, McKenna CJ, Codd MB, O'Rorke C, McCann HA, Sugrue DD, et al. Gender differences in the management and outcome of acute myocardial infarction in unselected patients in the thrombolytic era. Am J Cardiol 2000; 85: 921-926.
8. Milcent C, Dormont B, Durand-Zaleski I, Steg PG. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction. Microsimulation analysis of the 1999 Nationwide French Hospitals Datab. Circulation 2007; 115: 833-839.
9. Zhang Q, Shen J, Zhang RY, Qiu JP, Lu JD, Zhang Y, et al. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction. Chin Med J 2007; 120: 1862-1867.
10. Lopes NH, Paulitsch FS, Gois AF, Pereira AC, Stolf NA, Dallan LO, et al. Impact of number of vessels disease on outcome of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, and bypass Surgery Study (MASS). Eur J Cardiothorac Surg 2008; 33: 349-354.
11. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183.
12. Grundy SM, D'Agostino RB, Mosca L, Burke GL, Wilson PWF, Rader DJ, et al. Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute Workshop. Circulation 2004; 104: 491-496.
13. Srinivas VS, Brooks MM, Detre KM, King SB, Jacobs AK, Johnston J, et al. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation 2002; 106: 1627-1633.
14. Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King SB, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). Am J Cardiol 2002; 90: 1062-1067.
15. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001; 37: 1008-1015.
16. Lincoff AM. Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 2008; 107: 1556-1559.
17. Hammoud T, Tanguay J-F, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 2000; 36: 355-365.
18. Jokl R, Colwell JA. Arterial thrombosis and atherosclerosis in diabetes. Diabet Rev 1997; 5: 316-330.
19. Wang LF, Yang XC, Li WM, Ge YG, Wang HS, Zou YC, et al. The application of cipher TM drug-eluting stent in patient with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention. Chin J Intervent Cardiol (Chin) 2004; 12: 67-70.
20. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
21. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
22. Nordman AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 2006; 27: 2784-2814.
23. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007; 115: 1440-1455.
24. Zhang RY, Ni JW, Zhang JS, Hu J, Yang ZK, Zhang Q, et al. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J 2006; 119: 1176-1181.